Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metrics In Balance NV (XPAR:MLMIB) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Metrics In Balance NV's Enterprise Value for the quarter that ended in Dec. 2024 was €0.27 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Metrics In Balance NV's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €0.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLMIB vs MCK, COR, CAH: EV-to-EBIT Comparison
For the Medical Distribution subindustry, Metrics In Balance NV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metrics In Balance NV EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Metrics In Balance NV's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Metrics In Balance NV's EV-to-EBIT falls into.
Metrics In Balance NV's current Enterprise Value is €1.03 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Metrics In Balance NV's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €0.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metrics In Balance NV (XPAR:MLMIB) has a EV-to-EBIT of 42.71 as of Aug. 31, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Metrics In Balance NV and its competitors. This is 281% above median its historical median of 11.20.
Is Metrics In Balance NV's EV-to-EBIT too high?
Metrics In Balance NV's current EV-to-EBIT of 42.71 is 281% above median its 10-year median of 11.20. The Medical Distribution industry median EV-to-EBIT is 11.49. Metrics In Balance NV's value of 42.71 is 271.7% above this industry median. Overall, Metrics In Balance NV has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Metrics In Balance NV's EV-to-EBIT compare to MCK and COR?
Metrics In Balance NV's EV-to-EBIT of 42.71 can be compared against companies in the Medical Distribution industry. The industry median EV-to-EBIT is 11.49. Metrics In Balance NV's value of 42.71 is 271.7% above this benchmark. While the company's 10-year median is 11.20 vs. the industry median of 11.49, Metrics In Balance NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.49, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metrics In Balance NV's current EV-to-EBIT of 42.71 is 271.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Metrics In Balance NV and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metrics In Balance NV's current EV-to-EBIT is 42.71, which is 281% above median its own 10-year median of 11.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metrics In Balance NV stock overvalued right now?
Metrics In Balance NV (XPAR:MLMIB) has a current EV-to-EBIT of 42.71. The current EV-to-EBIT is 42.71, which is 281% above median its 10-year median of 11.20 and 271.7% above the Medical Distribution industry median of 11.49. Metrics In Balance NV's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Metrics In Balance NV (XPAR:MLMIB), the current EV-to-EBIT is 42.71 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Metrics In Balance NV is engaged in the sale of medical devices for the measurement, diagnosis, and resolution of disorders related to dental occlusion malfunction.
4GF Score
Get the complete analysis for XPAR:MLMIB
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLMIB has been successfully added to your 
